Growth hormone-releasing hormone (GHRH) and its agonists inhibit hepatic and tumoral secretion of IGF-1.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Growth hormone-releasing hormone (GHRH) and its agonists inhibit hepatic and tumoral secretion of IGF-1.
- Published In:
- Oncotarget, 9(47), 28745-28756 (2018)
- Authors:
- Cui, Tengjiao(2), Schally, Andrew V(41)
- Database ID:
- RPEP-03631
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03631APA
Cui, Tengjiao; Schally, Andrew V. (2018). Growth hormone-releasing hormone (GHRH) and its agonists inhibit hepatic and tumoral secretion of IGF-1.. Oncotarget, 9(47), 28745-28756. https://doi.org/10.18632/oncotarget.25676
MLA
Cui, Tengjiao, et al. "Growth hormone-releasing hormone (GHRH) and its agonists inhibit hepatic and tumoral secretion of IGF-1.." Oncotarget, 2018. https://doi.org/10.18632/oncotarget.25676
RethinkPeptides
RethinkPeptides Research Database. "Growth hormone-releasing hormone (GHRH) and its agonists inh..." RPEP-03631. Retrieved from https://rethinkpeptides.com/research/cui-2018-growth-hormonereleasing-hormone-ghrh
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.